Eye Care Supplements Market Size & Industry Report, 2033

Eye Care Supplements Market Overview

The Eye Care Supplements Market size was valued at USD 583.49 million in 2024 and is expected to reach USD 882.03 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033.

The Eye Care Supplements Market is experiencing a marked increase in demand due to the global rise in ocular disorders and aging populations. As of 2024, over 2.2 billion people suffer from some form of vision impairment worldwide, with nearly 1 billion cases attributed to preventable or treatable conditions, according to global health estimates. The market primarily consists of supplements formulated with ingredients like lutein, zeaxanthin, omega-3 fatty acids, and antioxidants such as vitamin C and E, zinc, and copper.

Notably, the prevalence of age-related macular degeneration (AMD) affects approximately 196 million people globally, with projections rising to 288 million by 2040. In the United States alone, around 11 million individuals have some form of AMD, and this demographic significantly contributes to the rising consumption of targeted supplements. The diabetic population, which stands at 537 million globally in 2024, also drives demand for supplements aimed at combating diabetic retinopathy. The market is witnessing robust product innovation, such as plant-based eye supplements, chewable tablets, and combination capsules tailored for specific conditions.

report_graphAlt

Key Findings

DRIVER: Growing geriatric population with increased susceptibility to ocular diseases.

COUNTRY/REGION: North America due to high healthcare awareness and product accessibility.

SEGMENT: Antioxidant supplements dominate due to widespread usage in preventing oxidative damage.

Eye Care Supplements Market Trends

The Eye Care Supplements Market is evolving rapidly, driven by consumer awareness and a spike in preventable eye diseases. The trend of preventive healthcare has led to increased adoption of supplements among both elderly and young adult demographics. A 2023 survey found that 67% of respondents above age 50 reported regular intake of eye vitamins to preserve vision. Supplements such as AREDS2-based formulations—containing lutein (10 mg), zeaxanthin (2 mg), vitamin E (400 IU), and zinc (80 mg)—are highly recommended by ophthalmologists.

Plant-based and vegan eye supplements are gaining momentum, with sales of plant-derived lutein and zeaxanthin supplements increasing by 23% in 2023 alone. Furthermore, digital eye strain caused by prolonged exposure to screens has led to the emergence of blue light protection supplements. A study conducted in Japan in 2024 revealed that 42% of office workers under 40 experienced relief from eye fatigue after 8 weeks of omega-3 supplementation.

Online retailing channels now account for over 60% of global sales, driven by ease of access, subscription models, and consumer reviews. In addition, countries such as South Korea and India have seen an uptick of 35% and 28%, respectively, in demand for localized eye care formulations targeting regional dietary habits and deficiency profiles.

Eye Care Supplements Market Dynamics

The global eye care supplements market is experiencing robust growth, driven by a confluence of demographic shifts, lifestyle changes, and increasing health awareness. Valued at approximately USD 2.4 billion in 2024, the market is projected to reach USD 4.09 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.9% during the forecast period .

DRIVER

Rising demand for preventive vision health products

Preventive eye care has emerged as a significant driver in the Eye Care Supplements Market, especially with the rise in age-related conditions. With over 703 million individuals aged 65 and older globally, nutritional supplementation is increasingly recommended to prevent diseases such as macular degeneration and cataracts. The National Eye Institute indicates that antioxidant-rich supplements can lower the risk of AMD progression by 25%. This driver is further strengthened by endorsements from ophthalmologists and inclusion in standard eye health protocols in North America and Europe.

RESTRAINT

Limited product awareness in developing regions

Despite rising demand in developed countries, limited awareness and affordability in developing regions remain key restraints. In sub-Saharan Africa and parts of Southeast Asia, less than 10% of the population is informed about the role of nutritional supplements in vision care. Furthermore, the lack of insurance reimbursement and high cost of premium supplements restricts consumer access. Distribution challenges and the dominance of traditional remedies also inhibit market penetration in low-income economies.

OPPORTUNITY

Growing interest in personalized nutrition

As of 2024, nearly 35% of nutraceutical consumers globally expressed interest in supplements tailored to their genetic profile and health data. This trend presents a major opportunity for eye care brands to develop DNA-based or biomarker-driven formulations. In Europe, 19 companies have launched AI-powered diagnostics that assess retinal health and recommend supplement regimens. This level of personalization is expected to broaden appeal across tech-savvy and health-conscious consumers.

CHALLENGE

Regulatory discrepancies across regions

The Eye Care Supplements Market is hindered by non-uniform regulations, with each country enforcing different ingredient approvals, label claims, and safety assessments. For instance, the European Food Safety Authority allows only 8 health claims related to eye health, while the U.S. FDA operates under DSHEA rules with looser controls. These inconsistencies complicate global expansion for supplement manufacturers and increase compliance costs, limiting new product introductions in international markets.

Eye Care Supplements Market Segmentation

The segmentation of the eye care supplements market is structured across product type, formulation, and distribution channel. By product type, the market is divided into lutein and zeaxanthin supplements, omega-3 fatty acids, antioxidants, vitamins A, C, and E, and multivitamin blends, with lutein and zeaxanthin leading due to their scientifically backed benefits in combating age-related macular degeneration and protecting against blue light exposure. In terms of formulation, the market is segmented into tablets, capsules, softgels, gummies, and powders. Capsules and softgels hold a significant share owing to their higher bioavailability and ease of consumption, while gummies are gaining popularity among younger consumers and those seeking flavored alternatives.

By distribution channel, the market includes online platforms, pharmacies, health and wellness stores, and supermarkets/hypermarkets. Online retail is growing rapidly due to convenience, global accessibility, and the rising influence of digital health awareness. Pharmacies remain a key channel, particularly for consumers seeking professional recommendations. This detailed segmentation helps manufacturers cater to diverse consumer preferences and expand their reach across various demographics and purchasing behaviors.

report_graphAlt

By Type

Antioxidants are the most consumed type, accounting for over 45% of all supplement usage in eye health. Clinical trials, such as the AREDS2 study, validate their efficacy in delaying disease progression. Vitamins C (500 mg), E (400 IU), and zinc (80 mg) are prevalent, with over 60 million units sold globally in 2023 alone.
Omega-3 fatty acids, particularly DHA and EPA, have shown a 27% improvement in dry eye symptoms after 3 months of use. In 2024, over 120 companies marketed omega-3-based eye supplements globally. These are commonly offered in doses of 1,000 mg/day and are popular among screen-heavy users.
Anti-inflammatory supplements include turmeric-based formulations (curcumin content 500 mg) and are often paired with piperine for enhanced bioavailability. They are used to manage inflammation-driven conditions such as uveitis and diabetic retinopathy, with adoption increasing 18% year-on-year in 2023.

By Application

General eye health supplements dominate the application category with over 70 million consumers in 2023 globally. These are commonly multivitamins containing a mix of lutein, zeaxanthin, and vitamins A, C, and E.
Supplements targeting AMD are prescribed to over 14 million patients annually. Lutein and zeaxanthin are the primary ingredients in this segment, and AREDS2 formulations continue to see annual growth of over 10 million prescriptions globally.
Over 65 million people suffer from cataracts, with 18 million cases causing blindness. Antioxidant supplements are recommended for slowing the oxidative damage associated with cataract progression, showing a 21% increase in market share in 2023.
Supplements targeting intraocular pressure, such as those containing ginkgo biloba and magnesium, are gaining traction. Nearly 4 million Americans were reported to have glaucoma in 2024, and 12% of them were on dietary supplements alongside medication.
With 103 million people suffering from diabetic retinopathy globally, alpha-lipoic acid and anti-inflammatory supplements are widely recommended. A 2023 clinical trial showed a 24% improvement in retinal cell integrity among users of targeted supplements over a 16-week period.

Regional Outlook For Eye Care Supplements Market

The Eye Care Supplements Market shows varied growth across regions, shaped by healthcare awareness, aging demographics, and regulatory infrastructure.

report_world_map

North America

In 2024, over 56% of Americans above age 50 reported regular intake of eye supplements. The U.S. accounts for over 40% of the global market in volume. High product penetration, frequent ophthalmic screenings, and a proactive healthcare culture drive the market in this region.

Europe

Germany, France, and the UK lead the European market, with over 18 million users recorded in 2023. EU-wide emphasis on dietary supplements for aging populations, combined with subsidized healthcare systems, enhances product accessibility. Germany alone saw a 21% rise in AREDS2 sales between 2022 and 2024.

Asia-Pacific

Asia-Pacific is witnessing a steep surge, especially in China, Japan, and India. In China, an estimated 30 million people take eye supplements due to increased screen time. Japan has over 17.4 million elderly citizens on macular degeneration treatments, many of which include dietary support.

Middle East & Africa

Market penetration remains modest due to low awareness, with only 3% of the population using eye care supplements regularly. However, urban regions in UAE and South Africa are emerging hubs, showing 12% growth in supplement usage in 2023.

List Of Top Eye Care Supplements Companies

Biosyntrx
Nordic Naturals
Bristol-Myers Squibb Company
Healths Harmony USA Supplements
NUSAPURE
Vitabiotics
Bausch & Lomb

Bausch & Lomb: Offers over 50 SKUs in eye care supplements, with distribution in 90+ countries. It holds over 12% global volume share in AREDS-based formulations.

Vitabiotics: Leads the European segment with its Visionace line, recording 15 million units sold in 2023 across 25 countries.

Investment Analysis And Opportunities

The Eye Care Supplements Market has become a lucrative segment within the broader nutraceutical industry. Investment in clinical trials for supplement efficacy rose by 19% in 2023, signaling a shift toward science-backed product portfolios. Companies such as Bausch & Lomb and Vitabiotics invested $80 million collectively in R&D for vision-specific SKUs.

Private equity firms are increasingly acquiring small nutraceutical companies with specialized eye care portfolios. Between Q1 2023 and Q1 2024, six acquisitions worth over $100 million were recorded globally in this space. Venture funding in plant-based and clean-label eye supplements also surged, with 28 start-ups raising over $60 million in 2023.

Retail expansion and e-commerce partnerships provide a key investment channel. Nearly 70% of eye supplement brands now operate on direct-to-consumer (D2C) platforms, which grew by 31% in order volumes in 2024. Growth is especially promising in Asia-Pacific, where 42% of new D2C brands launched localized eye care products.

New Product Development

Innovation is a defining feature of the Eye Care Supplements Market. In 2023, over 180 new SKUs were introduced globally. Notable developments include gummies for kids, chewable tablets for elderly users, and sachet formulations for ease of intake. Biosyntrx launched a lutein + astaxanthin blend shown to reduce macular pigment optical density loss by 17% over 6 months.

Nordic Naturals expanded into vegan DHA formulations sourced from algae, addressing demand in vegan populations, particularly in the U.S. and Germany. Bristol-Myers Squibb introduced dual-action supplements combining omega-3s and CoQ10 for diabetic vision care. Companies are also testing nanotechnology for improved bioavailability, with pilot trials underway in Japan and Switzerland.

Five Recent Developments

In February 2024, Bausch & Lomb launched “PreserVision Ultra,” a high-potency formulation of AREDS2 nutrients, in 10 international markets.
In August 2023, Vitabiotics released Visionace Pro+, targeting AMD patients, with a 22% market share rise in the UK.
Nordic Naturals launched a 100% vegan eye supplement line in April 2024, increasing their Asia-Pacific footprint by 18%.
In October 2023, Healths Harmony launched AI-personalized supplement kits, currently used by over 25,000 consumers monthly.
Bristol-Myers Squibb partnered with the Vision Foundation in December 2023 to distribute eye supplements to over 1.2 million underserved individuals.

Report Coverage Of Eye Care Supplements Market

This report provides an extensive analysis of the global Eye Care Supplements Market, with coverage across product types, applications, regions, and competitive landscapes. It includes insights into market trends such as the shift toward preventive eye care, personalized nutrition, and plant-based formulations. The report evaluates the impact of aging populations, screen-induced eye fatigue, and rising diabetic cases on supplement adoption.

Comprehensive segmentation by type—antioxidant, fatty acids, and anti-inflammatory supplements—is analyzed alongside application areas like macular degeneration, cataracts, and diabetic retinopathy. Each segment is evaluated with supporting data on usage trends, clinical evidence, and market adoption.

The report also outlines regulatory barriers, investment patterns, and innovation pipelines. It features profiles of key companies, highlighting market share, product offerings, and geographic presence. Furthermore, the report presents a detailed breakdown of regional performances and highlights five recent developments from 2023 to 2024.